Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Leucid Bio
company
About
Leucid is progressing novel cart therapies that produce a better and more durable response.
- London,England,United Kingdom
- 11 - 50
- http://www.leucid.com
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- £11.50M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part of Leucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£11.50M
Leucid Bio has raised a total of
£11.50M
in funding over 2 rounds. Their latest funding was raised on
Oct 21, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 21, 2021 | Series A | £11.50M | 5 |
Epidarex Capital
Vulpes Investment Management Pte Ltd
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
5
Leucid Bio is funded by 5 investors.
Epidarex Capital
and Vulpes Investment Management Pte Ltd
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Epidarex Capital
|
Yes | Series A |
|
Vulpes Investment Management Pte Ltd
|
Yes | Series A |
|
|
— | Series A |
British Business Bank
|
— | Series A |
Sofinnova Partners
|
— | Series A |
Employee Profiles
Number of Employee Profiles
7
Leucid Bio has 7 current employee profiles, including
Board observer Graziano Seghezzi
Board observer
Executive
Board member
Board member
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
